The International Diabetes Closed Loop (iDCL) Trial: Protocol 4
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
The International Diabetes Closed Loop (iDCL) Trial: Protocol 4 is a clinical trial[1].
Key Facts
- The International Diabetes Closed Loop (iDCL) Trial: Protocol 4 is in the country of Protocol 4 — country (P17): United States[2].
- The International Diabetes Closed Loop (iDCL) Trial: Protocol 4's instance of is recorded as Protocol 4 — instance of (P31): clinical trial[3].
- The International Diabetes Closed Loop (iDCL) Trial: Protocol 4's start time is recorded as +2020-07-15T00:00:00Z[4].
- The International Diabetes Closed Loop (iDCL) Trial: Protocol 4's end time is recorded as +2021-04-15T00:00:00Z[5].
- The International Diabetes Closed Loop (iDCL) Trial: Protocol 4's contributor to the creative work or subject is recorded as Protocol 4 — contributor to the creative work or subject (P767): National Institute of Diabetes and Digestive and Kidney Diseases[6].
- The International Diabetes Closed Loop (iDCL) Trial: Protocol 4's main subject is recorded as Protocol 4 — main subject (P921): continuous glucose monitor[7].
- The International Diabetes Closed Loop (iDCL) Trial: Protocol 4's main subject is recorded as Protocol 4 — main subject (P921): diabetes[8].
- The International Diabetes Closed Loop (iDCL) Trial: Protocol 4's number of participants is recorded as {'unit': '1', 'amount': '+35'}[9].
- The International Diabetes Closed Loop (iDCL) Trial: Protocol 4's title is recorded as The International Diabetes Closed Loop (iDCL) Trial: A Randomized Crossover Comparison of Adaptive Model Predictive Control (MPC) Artificial Pancreas Versus Sensor Augmented Pump (SAP)/Predictive Low Glucose Suspend (PLGS) in the Outpatient Setting in Type 1 Diabetes (DCLP4)[10].
- The International Diabetes Closed Loop (iDCL) Trial: Protocol 4's short name is recorded as DCLP4[11].
- The International Diabetes Closed Loop (iDCL) Trial: Protocol 4's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[12].
- The International Diabetes Closed Loop (iDCL) Trial: Protocol 4's ClinicalTrials.gov ID is recorded as NCT04436796[13].
- The International Diabetes Closed Loop (iDCL) Trial: Protocol 4's research intervention is recorded as Protocol 4 — research intervention (P4844): pancrelipase[14].
- The International Diabetes Closed Loop (iDCL) Trial: Protocol 4's research site is recorded as Protocol 4 — research site (P6153): Sansum Diabetes Research Institute[15].
- The International Diabetes Closed Loop (iDCL) Trial: Protocol 4's research site is recorded as Protocol 4 — research site (P6153): Stanford University[16].
- The International Diabetes Closed Loop (iDCL) Trial: Protocol 4's research site is recorded as Protocol 4 — research site (P6153): Joslin Diabetes Center[17].
- The International Diabetes Closed Loop (iDCL) Trial: Protocol 4's research site is recorded as Protocol 4 — research site (P6153): Mayo Clinic[18].
- The International Diabetes Closed Loop (iDCL) Trial: Protocol 4's research site is recorded as Protocol 4 — research site (P6153): Icahn School of Medicine at Mount Sinai[19].
- The International Diabetes Closed Loop (iDCL) Trial: Protocol 4's research subject recruitment status is recorded as Protocol 4 — research subject recruitment status (P8005): not yet recruiting[20].
- The International Diabetes Closed Loop (iDCL) Trial: Protocol 4's study type is recorded as Protocol 4 — study type (P8363): interventional study[21].